Atopic dermatitis (eczema) trials in South Korea

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  Where

  Ansan-si, Gwangju, Seoul

  Age

  6 months to 11 years

  People

  195 worldwide

  Run by

  LEO Pharma

  See details and how to joinNCT06311682 · EU 2023-503630-44-00
• Phase 2Taking people
  Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  Where

  Ansan, Seoul

  Age

  18 years to 100 years

  People

  224 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06947993 · EU 2024-519081-49-00
• Phase 2Taking people
  A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients

  Where

  Ansan

  Age

  19 years and over

  People

  162

  Run by

  HK inno.N Corporation

  See details and how to joinNCT07073677
• No phaseTaking people
  A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

  Where

  Seoul

  Age

  12 years and over

  People

  1,100

  Run by

  Pfizer

  See details and how to joinNCT05391061
• No phaseNot yet taking people in South Korea
  Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

  Where

  Ilsan

  Age

  19 years and over

  People

  102

  Run by

  Kang Stem Biotech Co., Ltd.

  See details and how to joinNCT04730024